Of note, based on IHC validation and experimental exploration, we corroborated that elevated expression of PLA2G2A was associated with GBC initiation, corresponding with the notion that PLA2G2A may display an initial beneficial effect against gastrointestinal mucosal inflammation whereas face the tradeoff of increased cancer risk22. This evidence concerns the gene PLA2G2A and cancer.